These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5631463)

  • 1. [Effects of flavon-7-ethyl oxyacetate on the cardiovascular system].
    Takenaka F; Takeya N; Tazume Y; Hayakawa T; Sakai M
    Kumamoto Igakkai Zasshi; 1967 Sep; 41(9):843-8. PubMed ID: 5631463
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of hexobendine on cardiac metabolism and blood supply.
    Raberger G; Kraupp O
    Brux Med; 1970 Sep; 50(9):645-50. PubMed ID: 5510366
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influencing of oxygen pressure in the myocardium by coronary dilators].
    Kadatz R; Diederen W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):156-9. PubMed ID: 5804228
    [No Abstract]   [Full Text] [Related]  

  • 4. The potentiating effect of methyl hesperidin on coronary vasodilation induced by adenosine or related compounds.
    Tsunoo M; Kawazoe K; Iwata Y; Kimura F
    Arzneimittelforschung; 1967 Aug; 17(8):979-80. PubMed ID: 5632073
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacologic viewpoint on so-called coronary dilator drugs].
    Faucon G; Evreux JC; Bazaugour R
    Therapie; 1970; 25(2):275-92. PubMed ID: 5526209
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of magnesium and nicardipine in the cardioplegic solution on the coronary arteries and myocardium].
    Shikano K; Nasu M; Miyamura K; Sakai T; Shomura S
    Rinsho Kyobu Geka; 1984 Sep; 4(5):556-60. PubMed ID: 6522980
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chromotropic, inotropic and coronary dilator actions of some heptaminol derivatives].
    Duchêne-Marullaz P; Cosnier D; Szabo S; Mollat F
    Therapie; 1968; 23(2):383-97. PubMed ID: 5701513
    [No Abstract]   [Full Text] [Related]  

  • 8. [Site of action of the coronary drug carbocromen].
    Alfes H; Schraven E; Möllmann H; Ostrowski J; Bigalke G; Nitz RE
    Fortschr Med; 1973 Jul; 91(19):837-43. PubMed ID: 4198875
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phenylbutylamino derivatives with a stimulating effect on the adrenergic beta-receptors and their action on the coronary circulation of dogs].
    Becker KH; Boltze KH; Lorenz D; Oberdörster G
    Arzneimittelforschung; 1966 Jul; 16(7):833-5. PubMed ID: 6014711
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular responses to intracoronary infusion of prostaglandin E-1, F-1 alpha and F-2 alpha.
    Hollenberg M; Walker RS; McCormick DP
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):66-73. PubMed ID: 5684294
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].
    Raff WK; Kosche F; Lochner W
    Arzneimittelforschung; 1972 Jan; 22(1):33-9. PubMed ID: 5066995
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of dilating agents on collateral coronary circulation and oxygen tension in the myocardium].
    Sapozhikov AV
    Farmakol Toksikol; 1968; 31(6):687-90. PubMed ID: 5713578
    [No Abstract]   [Full Text] [Related]  

  • 13. [Various aspects of the pharmacology of iproveratril, a new synthetic coronary dilator with anti-arrhythmic value].
    Melville KI; Shister HE; Mignault Jde L; Garvey L
    Union Med Can; 1969 Apr; 98(4):592-6. PubMed ID: 5355792
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of new vasoactive drug, 3(beta-diethylamino-ethyl)-4-methyl-7-(carbethoxy-methoxy)-2-oxy-1,2-chromen HC1 (Intensain) on the coronary circulation in dogs].
    Campus S; Pandolfo G; Dessy P; Gagna C; Uslenghi E
    Minerva Cardioangiol; 1967 Nov; 15(11):722-4. PubMed ID: 5616009
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the modification of circulatory depressant effect of bradycardia-inducing drugs].
    Grisk A; Stremmel D
    Acta Biol Med Ger; 1968; 20(6):805-23. PubMed ID: 5723838
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect on lipid metabolism of a coronary dilator: ethyl-7-oxyacetate flavone].
    Dupont JC; Sambin P; Detry R; Pont M
    Lyon Med; 1969 Apr; 221(16):941-7. PubMed ID: 5398694
    [No Abstract]   [Full Text] [Related]  

  • 17. Some effects of iproveratril (Isoptin) on the cardiovascular system.
    Nayler WG; McInnes I; Swann JB; Price JM; Carson V; Race D; Lowe TE
    J Pharmacol Exp Ther; 1968 Jun; 161(2):247-61. PubMed ID: 5650138
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the mechanism of action of coronary dilators].
    Kraupp O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):144-55. PubMed ID: 5804227
    [No Abstract]   [Full Text] [Related]  

  • 19. The change of intramyocardial oxygen partial pressure after acute coronary occlusion and administration of carbocromen.
    Koyama T; Scholtholt J; Nitz RE
    Arzneimittelforschung; 1972 Mar; 22(3):507-11. PubMed ID: 5067917
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacology and clinical effects of lidoflazine].
    Janssen PA
    Actual Pharmacol (Paris); 1970; 23():135-61. PubMed ID: 4948983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.